PFK-1 activity increases with the tumor size and positively correlates with markers of breast cancer invasiveness and aggressiveness [51], while high gene expression of platelet type phosphofructokinase 1 correlates with decreased patient survival [67]. This evidence concerns the gene PFKM and breast carcinoma.